Significant variability exists in adeno-associated virus (AAV) measurement methods, especially with polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA), highlighting the need ...

Viralgen and Axovia are set to form a partnership to progress the development and manufacturing of gene therapy for retinal ...

Traditional gene therapy vectors, such as adeno-associated viruses (AAVs), are limited by their small genetic payload capacity. To overcome this, the research team turned to AI-driven ...

such as adeno-associated viruses (AAV), marking a significant advancement in gene therapy. Electron microscopy confirmed the AI-designed nanocages achieved precise symmetrical structures as intended.

such as adeno-associated viruses (AAV), marking a significant advancement in gene therapy. Electron microscopy confirmed the AI-designed nanocages achieved precise symmetrical structures as intended.

Researchers are making strides in improving gene therapies for genetic diseases, particularly chronic kidney disease, using adeno-associated virus, or AAV, vectors. While AAV-based treatments have ...

Insmed is set to challenge the Duchenne muscular dystrophy (DMD) treatment space with its innovative gene therapy asset, ...